Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome

doi:10.4330/wjc.v16.i6.329

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (552)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

241

Figures (1-2)

Tables (1-4)

Sum=359

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=138

Publishing Process of This Article

Item

Count

Browse

Download

Sum=30

Jun 26, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Cardiol. Jun 26, 2024; 16(6): 329-338
Published online Jun 26, 2024. doi: 10.4330/wjc.v16.i6.329

Table 2 Changes over time in the lipoprotein(a), high-sensitivity C-reactive protein, creatine kinase, and creatine kinase-myocardial isoform from pre-percutaneous coronary intervention to 48 h after percutaneous coronary intervention

	Baseline	3 h	6 h	12 h	24 h	48 h	ANOVA²
Lp(a), mg/dL	19.0 ± 21.8	18.0 ± 20.6^b	18.0 ± 20.7^b	17.8 ± 20.1^b	18.2 ± 19.4^a	19.3 ± 19.2	< 0.001
hs-CRP¹, ng/mL	9584.4 (511.0, 4745.0)	9784.1 (405.0, 5668.0)	11295.9 (631.0, 7420.0)	16680.2 (1730.0, 14700.0)^b	34628.8 (6720.0, 47200.0)^b	57233.6 (14400.0, 82600.0)^b	< 0.001
CK¹, IU/L	567.1 (112.0, 594.0)	2410.3 (478.0, 3403.0)^b	2606.7 (579.0, 3893.0)^b	2228.0 (617.0, 3193.0)^b	1451.6 (454.0, 1918.0)^b	625.3 (200.0, 711.0)	< 0.001
CK-MB¹, IU/L	53.1 (10.0, 57.0)	221.1 (40.0, 309.0)^b	234.6 (54.0, 360.0)^b	176.8 (47.0, 261.0)^b	81.4 (26.0, 104.0)	21.8 (10.0, 26.0)^a	< 0.001

^aP < 0.05.

^bP < 0.01 vs baseline value.

¹Due to skewed distribution, medians (25%, 75% tile) are shown.

²All P values remained the same when age (10-year age group) or sex was included as a covariate (ANCOVA).

CK: Creatine kinase; CK-MB: Creatine kinase MB; hs-CRP: High-sensitivity C-reactive protein; PCI: Percutaneous coronary intervention.

Citation: Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, Akao H, Kitayama M, Kawai Y, Kajinami K. Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World J Cardiol 2024; 16(6): 329-338
URL: https://www.wjgnet.com/1949-8462/full/v16/i6/329.htm
DOI: https://dx.doi.org/10.4330/wjc.v16.i6.329